Urologix, Inc. (ULGX) Reports Q2 Loss of $0.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q2 EPS of ($0.09), versus ($0.04) reported last year. Revenue for the quarter came in at $2.92 million, versus $3.26 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LVMH edges past Q3 revenue estimates as fashion sales slip on China weakness
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- Apogee Enterprises (APOG) Tops Q2 EPS by 54c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
